ARCHIVES

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

This article is from The Cancer Letter archive.

Vol. 08 No. 28 | July 9, 1982

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future

September 28, 1990

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005